LYELL IMMUNOPHARMA INC (LYELXXXX)
Institutional ownership reported to the SEC as of Q2 2026, across 21 quarters.
1
Reporting holders
$9.7M
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Decheng Capital LLC | $9.7M | 692,050 | 1.33% | 7q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $9.7M | 692,050 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 1 | $13.9M | 692,050 | 0 | 0 | 0 | 0.0% |
| Q4 2025 | 1 | $21.3M | 692,050 | 0 | 1 | 0 | 0.0% |
| Q3 2025 | 2 | $10.6M | 650,353 | 0 | 1 | 0 | 0.0% |
| Q2 2025 | 5 | $21.6M | 2,440,610 | 0 | 0 | 5 | 0.0% |
| Q1 2025 | 104 | $77.9M | 145,158,972 | 14 | 21 | 32 | 0.0% |
| Q4 2024 | 95 | $91.3M | 143,043,222 | 18 | 30 | 21 | 0.0% |
| Q3 2024 | 105 | $165.0M | 119,996,391 | 15 | 26 | 27 | 0.0% |
| Q2 2024 | 109 | $182.8M | 125,693,995 | 13 | 31 | 39 | 0.0% |
| Q1 2024 | 111 | $283.4M | 126,778,463 | 19 | 33 | 36 | 0.0% |
| Q4 2023 | 104 | $241.9M | 124,439,531 | 17 | 32 | 21 | 0.0% |
| Q3 2023 | 93 | $169.8M | 115,462,304 | 12 | 40 | 19 | 0.0% |
| Q2 2023 | 90 | $361.9M | 113,802,167 | 14 | 28 | 31 | 0.0% |
| Q1 2023 | 84 | $272.3M | 115,374,428 | 18 | 25 | 18 | 0.0% |
| Q4 2022 | 72 | $372.4M | 107,337,132 | 11 | 26 | 9 | 0.0% |
| Q3 2022 | 87 | $823.5M | 112,339,393 | 21 | 32 | 12 | 0.0% |
| Q2 2022 | 73 | $692.6M | 105,615,458 | 11 | 26 | 18 | 0.6% |
| Q1 2022 | 79 | $505.8M | 99,521,989 | 17 | 35 | 10 | 0.6% |
| Q4 2021 | 76 | $662.4M | 85,551,369 | 24 | 27 | 9 | 0.0% |
| Q3 2021 | 62 | $1.2B | 82,534,460 | 28 | 11 | 10 | 0.0% |
| Q2 2021 | 52 | $1.3B | 79,701,894 | 52 | 0 | 0 | 0.0% |